Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies
about
Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding AntibodyImmune history profoundly affects broadly protective B cell responses to influenza.Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.Structure of the apo anti-influenza CH65 Fab.Influenza virus antigenicity and broadly neutralizing epitopes.Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.Variability in Humoral Immunity to Measles Vaccine: New Developments.Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteCharacterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural PolymorphismsGerminal center selection and the antibody response to influenzaThe HIV-1 envelope glycoprotein structure: nailing down a moving target.A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity.Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6.The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding.Potent peptidic fusion inhibitors of influenza virus.Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies.High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries.Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.Dissection of epitope-specific mechanisms of neutralization of influenza virus by intact IgG and Fab fragments.Structural insights into the design of novel anti-influenza therapies.Novel Platforms for the Development of a Universal Influenza Vaccine.Recent advances in veterinary applications of structural vaccinology.Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.
P2860
Q28552195-36A17848-C43E-4962-8446-1B905E1FD8A8Q30382131-7CB86310-DBC8-4ECC-98BC-E423A424C25BQ34520430-B25599C1-D0D4-44B3-B5E0-6ED6D0284850Q35063209-1496B1B9-A92F-4DFF-9906-6EEB2075B571Q35685270-ED273E5B-4EDA-4E44-9F33-83C2D539F095Q35758670-9975EA98-1D7B-49AA-B5B6-5F16365C716FQ36373260-D8BCAC1D-85F6-46AC-AE0D-3A0B3E82D96EQ36913606-C637D31A-C0DF-483E-BF46-1A0BDE3AA740Q36973969-F0FD4736-7830-4EF1-91EF-4B97C9C2BAF5Q38615063-6ACF2683-35FB-4A87-850D-2A856A899FEEQ39108789-E232C047-91C8-4BCF-8CB1-A70809A890F4Q39397313-6C48605A-4E36-4D42-9D32-6351F8AE93AFQ40043685-ED35ED63-55C9-4D08-8638-04C40DB6AB85Q40120056-E9BAE147-F5A4-4564-99F9-8B2DCCEE4C77Q40158695-F2DF24D0-BB2C-4100-A885-D37BE5BF333FQ40201534-C735B473-D582-42E0-9733-5661CC4AD7B8Q40353525-3C2D77BF-A27D-402B-B24B-34366A4A4FA5Q40606158-A40492A0-A36C-4D3D-BE16-98F67E626B54Q40617500-B627EC2F-2F36-4ABC-B274-E906F160FCB7Q41922286-53F12A1B-0A42-486F-B680-CE82007D2D97Q41925677-4B2F19F2-E76E-48AA-B414-C3B30EAA5E3CQ42371906-0A204B18-70F2-4DBC-9AC9-0EC0AF387170Q45325444-56A5E30E-B592-4F04-BCD1-EFA23160796EQ47137425-5A16D42C-5AD3-483A-909C-E17E496D6E51Q47562645-519BD4CB-3D66-48D0-B12D-9DB85E8623E5Q48113181-983242BA-D924-4FFC-8DF1-CD2D1DB0FA3BQ52599675-80860806-9FF9-4198-98B1-D6CE2640D092Q52650429-5D7F8CA5-3798-4167-B39F-9EE91B306B65Q52673291-1177DFF2-D6A8-4640-80C6-C12CF96086CEQ55518397-B9B0E7DA-036A-4E05-BEE8-ACD44B991D99Q55689231-4F992427-02B8-4257-B10D-117D826D713D
P2860
Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Structural characterization of ...... adly cross-reactive antibodies
@ast
Structural characterization of ...... adly cross-reactive antibodies
@en
Structural characterization of ...... adly cross-reactive antibodies
@nl
type
label
Structural characterization of ...... adly cross-reactive antibodies
@ast
Structural characterization of ...... adly cross-reactive antibodies
@en
Structural characterization of ...... adly cross-reactive antibodies
@nl
prefLabel
Structural characterization of ...... adly cross-reactive antibodies
@ast
Structural characterization of ...... adly cross-reactive antibodies
@en
Structural characterization of ...... adly cross-reactive antibodies
@nl
P2860
P3181
P356
P1476
Structural characterization of ...... adly cross-reactive antibodies
@en
P2093
Ian A. Wilson
Peter S. Lee
P2860
P304
P3181
P356
10.1007/82_2014_413
P407
P577
2015-01-01T00:00:00Z